- Home
- Companies
- IONIQ Sciences, Inc.
- News
- IONIQ Receives Three Awards including ...
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’
Source: IONIQ Sciences, Inc.
- By: Andy RobertsonSalt Lake City, UT -- IONIQ Sciences is humbled to be recognized with three separate awards from ‘Global 100‘ especially during ‘Lung Cancer Hope Month.’ These three awards and earlier designation by the US FDA as a ‘Breakthrough Device‘ is further validation of our growing clinical evidence library from seven trials at 24 sites with 1.2K subjects and more than 20M data points.
- Best Medical Technology Company 2022
- Most Innovative Non-Invasive Lung Cancer Testing Solution 2022: The IONIQ ProLung Test – USA
- Best Lung Cancer Predictive Analytics Risk Testing Platform: The IONIQ ProLung Test – USA for 2022
Click here to visit Global 100’s magazine to read more about our awards (pgs 10 and 32).
The clinical evidence across cancer types continues to demonstrate that early detection saves money and lives. When cancer can be diagnosed in the earliest and most-treatable stages, survival rates are ~90%. Early detection matters most and IONIQ Sciences is focused on making it a reality with our non-invasive bioimpedance technology.
-
Most popular related searches
Customer comments
No comments were found for IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’. Be the first to comment!